TScan Therapeutics Inc (TCRX)

[FACT-MASTER]

TCRX: Wedbush reiterates "outperform" rating

https://www.marketbeat.com/stocks/NASDAQ/TCRX/price-target/

Short Interest on a steady decline since September 2023

1/15/2024 260,300 shares $1.56 million -14.6% 0.7% 2 $6.00
12/31/2023 304,700 shares $1.78 million -14.1% 0.8% 2.3 $5.83
12/15/2023 354,700 shares $1.76 million -5.0% 0.9% 3.1 $4.95
11/30/2023 373,300 shares $2.44 million -10.3% 1.0% 3.1 $6.53
11/15/2023 416,000 shares $1.98 million -11.6% 1.1% 3.5 $4.76
10/31/2023 470,700 shares $1.81 million -10.5% 1.2% 4.4 $3.85
10/15/2023 526,000 shares $1.77 million -7.2% 1.4% 5.1 $3.37